Application of secoisolariciresinol diglucoside and flaxseed polysaccharide in preparation of health care product for improving osteoporosis
By preparing health products using a specific ratio of flaxseed lignans and flaxseed polysaccharides, the synergistic mechanism between flaxseed polysaccharides and flaxseed lignans in improving osteoporosis has been solved, resulting in significant improvements in bone density and biomechanical properties, regulation of gut microbiota, and providing a theoretical basis for the development of functional foods.
Patent Information
- Application Number
- CN202610521456.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2026-04-20
- Publication Date
- 2026-06-09
AI Technical Summary
Existing technologies have failed to effectively explore the synergistic mechanism of flaxseed polysaccharides and flax lignans, resulting in a lack of reports and industrial applications regarding their combined application and synergistic effect in improving osteoporosis.
A flax lignan to flaxseed polysaccharide mass ratio of (1~4):1 was used to prepare a health product to improve osteoporosis. It can inhibit abnormal weight gain caused by ovariectomy, increase serum estrogen levels, reduce related bone metabolism indicators, improve femoral bone density and biomechanical properties, and regulate intestinal flora.
It significantly improves postmenopausal osteoporosis, increases bone mineral density, bone volume fraction, trabecular bone number and connectivity density, reduces trabecular bone separation, improves femoral biomechanical properties, and regulates gut microbiota, providing a theoretical basis for the development of flaxseed functional foods.